FDA approves Mozobil for transplants (UPI) WASHINGTON, Dec. 19 (UPI)
FDA approves Mozobil for transplants (UPI)
WASHINGTON, Dec. 19 (UPI) -- The U.S. Food and Drug Administration has approved the drug Mozobil for treatment of adults with multiple myeloma or non-Hodgkin's lymphoma.
2008 round-up: US regulation (Nutraingredients.com)
The top story involved the spectacular demise of Steve Warshak, the founder of Berkeley Premium Nutraceuticals maker of the high-profile male enhancement supplements promoted in TV commercials by Smiling Bob.
Air-Based Asthma Medication Inhaler That Does Not Use A Refrigerant Propellant (Medical News Today)
Inhalers used for delivering albuterol, a fast-acting bronchial dialator, currently use propellants such as ozone-depleting CFC's, which are banned by the FDA beginning December 31st, 2009, or replacement HFA's. Both propellants are also used as industrial refrigerants and eject the medicine, albuterol, at near-supersonic speeds.